LAS VEGAS (KTNV) — An experimental antibody drug being used to treat President Donald Trump for COVID-19 is also being clinically tested in Las Vegas.
A health update from The White House states that President Trump received a single eight-gram dose of Regeneron's polyclonal antibody cocktail.
RELATED: Trump tweets video update from Walter Reed Medical Center
Dr. Daliah Wachs says the drug is meant to cut down the time of the sickness and make symptoms less severe.
“They used a couple different antibodies, and what those antibodies do is neutralize the virus,” says Dr. Wachs.
While the hope is for the patient to return to health fast, Dr. Wachs says the results of an antibody infusion may not be immediate.
“You might almost still see an increase of symptoms and then come down in a few days,” says Dr. Wachs.
RELATED:Doctor says Trump 'not yet out of the woods'
The effectiveness of the Regeneron cocktails in the COVID-19 fight is still not exactly clear.
The co-founder of Regeneron Pharmaceuticals spoke to Good Morning America and says the same technology was used to fight another virus outbreak in the past - Ebola.
“We pioneered the technologies to deliver this cocktail over the last 20 years and it has an impressive track record of delivery, some of the world's most important and safest medicines,” says George Yancopoulos.
Yancopoulos could not confirm if First Lady Melania Trump received any treatment of the antibody-drug, and was only able to confirm that they delivered the medicine to The White House.
Regeneron is looking for people to participate in Las Vegas.
